HHealthcare Read More Rare disease is taking his sight. Access to a treatment is hard to getSeptember 10, 2026 Judy and Courtney Stecker with their sons, Read (left) and Wheeler (right). Judy and Courtney Stecker CNBC Cures…
AArtificial intelligence Read More The startup using AI to help build custom treatments for rare diseasesAugust 18, 2026 Jacalyn Lee, founder of The DAND Alliance, and her youngest daughter Isla. Jacalyn Lee CNBC Cures is proudly…
BBusiness Read More Court rules companies can’t import Gilead medications from overseasAugust 16, 2026 Nikos Pekiaridis | Nurphoto | Getty Images A court ruling this week in favor of Gilead Sciences could…
HHealthcare Read More CAMP4 advances rare disease treatment for SYNGAP1 into human trialsAugust 6, 2026 CNBC Cures is proudly underwritten by Alexion, AstraZeneca Rare Disease, whose support enables our journalism to elevate stories…
HHealthcare Read More AstraZeneca stock dives 9% after heart drug trial misses targetJuly 9, 2026 Shares of AstraZeneca fell as much as 9% after a late-stage clinical trial for a heart disease failed…
AArtificial intelligence Read More AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of successJune 5, 2026 AstraZeneca CEO Pascal Soriot said artificial intelligence is helping drugmakers develop medicines faster and make smarter decisions throughout…
MMedication Read More Reality of Trump’s drug pricing to set in over next 18 monthsApril 28, 2026 Vas Narasimhan, chief executive officer of Novartis AG, during an announcement in the Roosevelt Room of the White…
HHealthcare Read More Eli Lilly to acquire cancer drug maker Kelonia in deal worth up to $7BApril 20, 2026 Eli Lilly will acquire biotech company Kelonia Therapeutics in a deal worth up to $7 billion, the company…
HHealthcare Read More Gilead to acquire cancer therapy developer ArcellxFebruary 23, 2026 A Gilead Sciences office is shown in Foster City, California, U.S. May 1, 2018. Stephen Lam | Reuters…
MMedication Read More More drugs should be over-the-counterFebruary 18, 2026 Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…
MMedication Read More U.S. employer health plans tap prescriptions that feds say are illegalNovember 13, 2025 Every step is a struggle for Bruce Zimmerman, whose health has been deteriorating since he was diagnosed with…
HHealthcare Read More Eli Lilly, Merck, Gilead and AbbVie earnings previewOctober 28, 2025 The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday,…